Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joseph Melenhorst

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Genome Biology|January 19, 2019
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificityChristopher L Nobles, Shantan Reddy, January Salas-McKee, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 7, 2008
Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramersPratip K Chattopadhyay, J Joseph Melenhorst, Kristin Ladell, et al.
Nature Biomedical Engineering|October 10, 2025
Fine tuning towards the next generation of engineered T cellsTham T Nguyen, Patrick Ho, Sarah Staudt, et al.
Blood|August 2, 2003
Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastaseFrank El-Ouriaghli, Elaine Sloand, Lori Mainwaring, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2011
Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cellsJ Joseph Melenhorst, Phillip Scheinberg, Ann Williams, et al.
Blood|November 11, 2008
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrowJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Stem Cell Research|December 24, 2014
Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cellsSawa Ito, A John Barrett, Amalia Dutra, et al.
Signal Transduction and Targeted Therapy|July 31, 2020
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphomaJianshu Wei, Yang Liu, Chunmeng Wang, et al.
Frontiers in Immunology|December 19, 2018
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical SuccessKristen B Long, Regina M Young, Alina C Boesteanu, et al.
Cancer Research Communications|March 16, 2023
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLLMcKensie A Collins, In-Young Jung, Ziran Zhao, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Genome Biology|January 19, 2019
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificityChristopher L Nobles, Shantan Reddy, January Salas-McKee, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 7, 2008
Techniques to improve the direct ex vivo detection of low frequency antigen-specific CD8+ T cells with peptide-major histocompatibility complex class I tetramersPratip K Chattopadhyay, J Joseph Melenhorst, Kristin Ladell, et al.
Nature Biomedical Engineering|October 10, 2025
Fine tuning towards the next generation of engineered T cellsTham T Nguyen, Patrick Ho, Sarah Staudt, et al.
Blood|August 2, 2003
Clonal dominance of chronic myelogenous leukemia is associated with diminished sensitivity to the antiproliferative effects of neutrophil elastaseFrank El-Ouriaghli, Elaine Sloand, Lori Mainwaring, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 11, 2011
Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cellsJ Joseph Melenhorst, Phillip Scheinberg, Ann Williams, et al.
Blood|November 11, 2008
High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrowJ Joseph Melenhorst, Phillip Scheinberg, Pratip K Chattopadhyay, et al.
Stem Cell Research|December 24, 2014
Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cellsSawa Ito, A John Barrett, Amalia Dutra, et al.
Signal Transduction and Targeted Therapy|July 31, 2020
The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphomaJianshu Wei, Yang Liu, Chunmeng Wang, et al.
Frontiers in Immunology|December 19, 2018
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical SuccessKristen B Long, Regina M Young, Alina C Boesteanu, et al.
Cancer Research Communications|March 16, 2023
Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLLMcKensie A Collins, In-Young Jung, Ziran Zhao, et al.
Pageof 10